Skip to main content

Oral Piroxicam Plus Levonorgestrel Increases Efficacy of Emergency Contraception

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Aug. 17, 2023 -- Oral piroxicam coadministered with levonorgestrel improves the efficacy of emergency contraception (EC), according to a study published online Aug. 16 in The Lancet.

Raymond Hang Wun Li, M.D., from the University of Hong Kong, and colleagues conducted a randomized trial in a major community sexual and reproductive health service in Hong Kong. Women who required levonorgestrel EC within 72 hours of unprotected sexual intercourse were recruited and randomly assigned to a single supervised dose of levonorgestrel 1.5 mg plus piroxicam 40 mg or placebo orally (420 women in each group). The pregnancy status was noted by history or pregnancy test at follow-up one to two weeks after the next expected period.

The researchers found that one and seven (0.2 and 1.7 percent, respectively) of efficacy-eligible women in the piroxicam and placebo groups were pregnant. Levonorgestrel plus piroxicam and levonorgestrel plus placebo prevented 94.7 and 63.4 percent of expected pregnancies, respectively. In terms of the proportion of women with advancement or delay of their next period or in the adverse event profile, no significant differences were noted between the two groups.

"This randomized double-blind placebo-controlled trial showed for the first time that oral piroxicam 40 mg co-administered with levonorgestrel significantly improves EC efficacy without increasing the likelihood of adverse events," the authors write. "This can be considered where levonorgestrel EC is the option of choice."

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Transient Increase Seen in Contraceptive Use After Dobbs Decision

MONDAY, April 15, 2024 -- A transient increase in contraceptive use was seen following the Dobbs v Jackson Women's Health Organization decision, with a return to overall downward...

Consumers Are Most Frequent Posters of Contraception Info on Social Media

MONDAY, April 1, 2024 -- Social media is a popular conduit for birth control information, according to a study published online Feb. 7 in Contraception and Reproductive...

Teen Pregnancy, Sexual Health Care Use Lower Than Expected During Pandemic

FRIDAY, Feb. 2, 2024 -- During the COVID-19 pandemic, population-level rates of adolescent pregnancy and sexual health-related care utilization were lower than expected, according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.